Trade Summary

Yesterday, Rothblatt Martine A, serving as CHAIRPERSON, CEO at United Therapeutics Corp (UTHR), sold 9,500 shares at $578.65 per share, for a total transaction value of $5,497,166.00. Following this transaction, Rothblatt Martine A now holds 679,797 shares of UTHR.

This sale represents a 1.00% decrease in Rothblatt Martine A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 13, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 5:54 PM ET, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.